Literature DB >> 15818183

Community-acquired pneumonia in children.

Constantine A Sinaniotis1, Athanassios C Sinaniotis.   

Abstract

PURPOSE OF REVIEW: This review highlights recent developments in the diagnosis, etiology, therapy, and prevention of community-acquired pneumonia in children. RECENT
FINDINGS: Sensitive new diagnostic methods have increased the detection rate of the causative agent up to 94%. Streptococcus pneumoniae is the most prevalent bacterial pathogen in all ages. Polymerase chain reaction is a rapid and sensitive method for the detection of Chlamydia pneumoniae and Mycoplasma pneumoniae, which have gained greater importance in recent years. During the period covered by this review, two new agents causing pneumonia were extensively studied. Human metapneumonovirus detected in young children is a leading cause of respiratory disease during the first years of life. A novel coronavirus was identified as the causative agent of severe respiratory syndrome, a new respiratory illness that affects adults and children. One multicenter trial concluded that nonsevere pneumonia can be treated with a short course of oral amoxicillin and a multicenter international study showed that children with severe pneumonia have similar outcomes whether treated with oral amoxicillin or parenteral penicillin, but more data are needed to demonstrate the safety and efficacy of such regimens.
SUMMARY: The continued evolution of bacterial resistance highlights the need for appropriate use of antibacterials. Improved diagnostic techniques will aid the treatment of children with community-acquired pneumonia. Aggressive vaccination with the pneumococcal conjugate vaccine and other available vaccines as well as the development of new vaccines will aid the prevention of respiratory disease in children.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818183     DOI: 10.1097/01.mcp.0000159831.82529.85

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  12 in total

1.  The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia.

Authors:  Eran Lavi; Oded Breuer
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

2.  Effects of bacterial and viral co-infections of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children's Hospital between 2010 and 2014.

Authors:  Qing Song; Bao-Ping Xu; Kun-Ling Shen
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  Isabela R Marques; Izabela P Calvi; Sara A Cruz; Luana M F Sanchez; Isis F Baroni; Christi Oommen; Eduardo M H Padrao; Paula C Mari
Journal:  Eur J Pediatr       Date:  2022-09-06       Impact factor: 3.860

4.  Clinical Utility of Respiratory Scores at Admission for Estimating the Definitive Microbiological Diagnosis in Lower Respiratory Tract Infections in Infants.

Authors:  And Demir; Nihal Özdemir Karadas; Ulas Karadas
Journal:  Glob Pediatr Health       Date:  2022-06-27

5.  Pediatric presentation of pulmonic effusion secondary to influenza.

Authors:  Norma L Cooney; Derek R Cooney; Brian Kloss
Journal:  Int J Emerg Med       Date:  2009-08-01

6.  Incidence of respiratory virus-associated pneumonia in urban poor young children of Dhaka, Bangladesh, 2009-2011.

Authors:  Nusrat Homaira; Stephen P Luby; William A Petri; Raija Vainionpaa; Mustafizur Rahman; Kamal Hossain; Cynthia B Snider; Mahmudur Rahman; A S M Alamgir; Farzina Zesmin; Masud Alam; Emily S Gurley; Rashid Uz Zaman; Tasnim Azim; Dean D Erdman; Alicia M Fry; Joseph Bresee; Marc-Alain Widdowson; Rashidul Haque; Eduardo Azziz-Baumgartner
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

7.  Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Sun Young You; Hye Jeong Jwa; Eun Ae Yang; Hong Ryang Kil; Jae Ho Lee
Journal:  Allergy Asthma Immunol Res       Date:  2013-11-15       Impact factor: 5.764

Review 8.  Evidence for short duration of antibiotic treatment for non-severe community acquired pneumonia (CAP) in children - are we there yet? A systematic review of randomised controlled trials.

Authors:  Shalom Ben-Shimol; Varda Levy-Litan; Oana Falup-Pecurariu; David Greenberg
Journal:  Pneumonia (Nathan)       Date:  2014-12-01

9.  Epidemiology and clinical characteristics of pathogens positive in hospitalized children with segmental/lobar pattern pneumonia.

Authors:  Yanxia Wang; Liji Ma; Ying Li; Yuyun Li; Yanfei Zheng; Xiaoyue Zhang
Journal:  BMC Infect Dis       Date:  2020-03-06       Impact factor: 3.090

10.  Human metapneumovirus associated with community-acquired pneumonia in children in Beijing, China.

Authors:  Guilan Lu; Jianguo Li; Zhengde Xie; Chunyan Liu; Li Guo; Guy Vernet; Kunling Shen; Jianwei Wang
Journal:  J Med Virol       Date:  2012-10-23       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.